Stephen Mayo, Director at Sarepta Therapeutics, Inc. (SRPT), sold 7,239 shares at $17.02 ($123K) on 2026-03-12, disclosed to the SEC on 2026-03-13.
Seasonal sale ($123k) by Director — this insider has traded SRPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SRPT | SELL | 2022-11-21 | $189K | — | Filing → |